腫瘤消融市場規模、佔有率、成長分析：按技術、按治療、按應用、按地區 - 行業預測，2024-2031 年

2022年全球腫瘤消融市場規模為14.8億美元，將從2023年的16.8億美元成長到2031年的16.8億美元，預計在預測期（2024-2031年）複合年成長率為13.5%。 46.3億美元。

癌症發生率的增加和對更安全治療方案的需求不斷增加是推動市場成長的主要因素。世界衛生組織 (WHO) 預測，到 2030 年，全球每年將診斷出 1,000 至 1,100 萬新癌症病例。在低收入國家，新發癌症病例預計將增加 80% 以上，而高所得國家則增加 40%。癌症患者數量的快速增加，加上對微創和非侵入性治療方案的強烈渴望，預計將在未來幾年推動市場的大幅擴張。外科醫生和患者對微創手術的偏好可能會增加對先進腫瘤消融技術的需求。這些技術具有恢復更快、提高患者舒適度和縮短手術時間的優點。與傳統治療不同，先進的消融方法通常在門診進行，不需要住院，這可以降低整體醫療費用。消融對於小腫瘤尤其有效，其利用率與癌症檢出率密切相關。然而，2020 年，市場因 COVID-19 大流行而受到重大影響，由於篩檢活動減少，新診斷的癌症大幅減少。根據《Our World in Data》的研究，超過 70% 的癌症診斷發生在 50 歲以上的人群中，隨著人口老化，這一數字預計還會增加。隨著老齡化相關的身體機能下降增加癌症盛行率，對非侵入性切除術的需求預計將會增加。旨在提高精度、可操作性和成本效益的技術進步正在推動市場創新。冷卻射頻消融等新技術使用外部冷卻探頭來縮小病灶範圍並減輕疼痛，看來將在未來的市場擴張中發揮關鍵作用。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 市場關鍵成功因素
• 價值鏈分析
• 主要投資機會
• 市場吸引力指數
• 生態系繪圖
• 價格分析
• 專利分析
• 波特五力分析
• 貿易分析
• 供應鏈分析
• 監管分析
• 技術分析
• 案例研究分析

腫瘤消融市場：依技術分類

• 市場概況
• 射頻消融術
• 微波消融
• 冷凍療法
• 不可逆電穿孔消融
• 高強度聚焦超音波（HIFU）
• 其他技術

腫瘤消融市場：依治療方式分類

• 市場概況
• 手術消融
• 腹腔鏡消融術
• 經皮消融術

腫瘤消融市場：依應用分類

• 市場概況
• 腎癌
• 肝癌
• 乳癌
• 肺癌
• 攝護腺癌
• 其他癌症

腫瘤消融市場：按產品類型

• 市場概況
• 發電機
• 探頭/電極
  • 射頻消融術探頭
  • 微波消融探頭
  • 其他探頭/電極

腫瘤消融市場：依最終用戶分類

• 市場概況
• 醫院/診所
• 癌症護理中心
• 其他最終用戶

腫瘤消融市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（US）
• Johnson & Johnson（Ethicon, Inc.）（US）
• AngioDynamics, Inc.（US）
• EDAP TMS SA（France）
• SonaCare Medical, LLC（US）
• Merit Medical Systems, Inc.（US）
• Misonix, Inc.（US）
• HealthTronics, Inc.（US）
• Galil Medical Ltd.（US）
• IceCure Medical Ltd.（Israel）
• Monteris Medical, Inc.（Canada）
• Hologic, Inc.（US）
• Symple Surgical Inc.（US）
• BVM Medical Limited（UK）
• Ablatherm（Esaote SpA）（Italy）
• Bioventus LLC（US）
• CEVOTEC（Germany）
• Fujifilm Holdings Corporation（Japan）
• InSightec Ltd.（Israel）
• Philips Healthcare（Netherlands）

Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).

The growing incidence of cancer and the increasing demand for safer therapeutic options are major factors fueling market growth. The World Health Organization (WHO) projects that by 2030, there will be between 10 to 11 million new cancer cases diagnosed globally each year. In low-income countries, new cancer cases are expected to rise by over 80%, compared to a 40% increase in high-income nations. This surge in cancer cases, combined with the strong desire for minimally and non-invasive treatment options, is anticipated to drive significant market expansion in the coming years. The preference for minimally invasive procedures among both surgeons and patients is likely to enhance the demand for advanced tumor ablation techniques. These methods offer advantages such as quicker recovery, improved patient comfort, and shorter procedure times. Unlike traditional treatments, advanced ablation procedures are often performed on an outpatient basis, eliminating the need for hospital admission and reducing overall healthcare costs. Ablation is particularly effective for small tumors, and its utilization is closely linked to cancer detection rates. However, the market experienced a notable impact in 2020, as the COVID-19 pandemic led to a significant reduction in new cancer diagnoses due to decreased screening activities. A survey by Our World in Data highlights that over 70% of cancer diagnoses occur in individuals over 50, a number expected to rise with the aging population. As age-related decline in bodily functions increases the prevalence of cancer, the demand for non-invasive ablation procedures is expected to grow. Technological advancements aimed at improving accuracy, mobility, and cost-effectiveness are driving market innovation. Emerging techniques, such as cooled radiofrequency ablation, which uses externally chilled probes to enhance lesion size and provide pain relief, are poised to play a significant role in the market's future expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Ablation Market Segmental Analysis

The global tumor ablation market is segmented by technology, application, treatment, and region. Based on technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, High-intensity-focused Ultrasound (HIFU), and other ablation technologies. Based on treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Based on end users, the market is segmented into Hospitals & Clinics, Cancer Care Centers, and other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Tumor Ablation Market

The increasing global incidence of cancer, especially lung, liver, kidney, and breast cancers, is significantly driving the growth of the tumor ablation market. Tumor ablation techniques are gaining prominence as they provide minimally invasive alternatives to traditional surgery, offering effective treatment options for localized tumors. These methods are particularly valuable for patients who may not be eligible for conventional surgical procedures. By offering less invasive treatment options, tumor ablation techniques address a critical need in the oncology field. They present a viable solution for patients with localized tumors, allowing for effective management of cancer while minimizing the risks and recovery times associated with more invasive surgical interventions.

Restraints in the Global Tumor Ablation Market

Tumor ablation procedures can be costly, particularly when advanced technologies and imaging guidance are used. The high expenses associated with specialized equipment, consumables, and skilled healthcare professionals can restrict access to these treatments, especially in resource-limited regions and developing countries. The financial burden of these procedures can limit their availability and make them less accessible to patients in areas with constrained healthcare resources. This cost factor poses a significant challenge to the widespread adoption of tumor ablation techniques across diverse healthcare settings.

Market Trends of the Global Tumor Ablation Market

The tumor ablation market is experiencing ongoing technological progress, resulting in the emergence of more sophisticated and precise ablation techniques. Innovations include the incorporation of imaging technologies for real-time guidance, the application of robotic systems to boost precision, and the introduction of novel energy sources for ablation. These advancements contribute to improved efficacy and safety in tumor ablation procedures. As technology continues to evolve, these developments are significantly enhancing the effectiveness of tumor ablation treatments. The integration of advanced imaging and robotic systems, along with new energy modalities, ensures greater accuracy and safety during procedures, thereby improving overall patient outcomes.

Table of Contents

Introduction

• Objectives of the study
• Definitions
• Market scope

Research methodology

• Information procurement
• Secondary & primary data sources
• Market size estimation
• Market assumptions & limitations

Executive summary

• Market overview outlook
• Supply demand trend analysis
• Segmental opportunity analysis

Market dynamics & outlook

• Market dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters' analysis
  • Competitive rivalry
  • Threat of substitute products
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key market insights

• Key success factors of the market
• Value chain analysis
• Top investment pockets
• Market attractive index
• Ecosystem mapping
• Pricing analysis
• Patent Analysis
• Porter's five forces analysis
• Trade analysis
• Supply chain analysis
• Regulatory analysis
• Technology analysis
• Case study analysis

Global Tumor Ablation Market by Technology

• Market overview
• Radiofrequency ablation
• Microwave ablation
• Cryoablation
• Irreversible electroporation ablation
• High-intensity-focused Ultrasound (HIFU)
• Other ablation technologies

Global tumor ablation market by Treatment

• Market overview
• Surgical ablation
• Laparoscopic ablation
• Percutaneous ablation

Global tumor ablation market by Application

• Market overview
• Kidney cancer
• Liver cancer
• Breast cancer
• Lung cancer
• Prostate cancer
• Other cancer

Global tumor ablation market by Product Type

• Market overview
• Generators
• Probes/electrodes
  • Radiofrequency Ablation Probes
  • Microwave Ablation Probes
  • Other Probes/Electrodes

Global tumor ablation market by End Use

• Market overview
• Hospitals & Clinics
• Cancer Care Centers
• Other End Users

Global tumor ablation market size by Region

• Market overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle east & Africa (MEA)
  • GCC countries
  • South Africa
  • Rest of MEA

Competitive landscape

• Top 5 player comparison
• Market positioning of key players, 2023
• Strategies adopted by key market players
• Recent activities in the market
• Key companies market share (%), 2023

Key company profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Ethicon, Inc.) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Misonix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthTronics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical Ltd. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monteris Medical, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Symple Surgical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVM Medical Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ablatherm (Esaote S.p.A.)(Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEVOTEC (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments